Safety and Efficacy of Streptococcus salivarius K12 for Treatment of Oral Mucositis Associated With Radiotherapy for Head and Neck Tumors
Read it now on PracticeUpdate.com
Related Articles
Elon Musk Bought a Texas Compound for His 11 Kids and Their Mothers
As the billionaire warns of population collapse and the moral obligation to have children, he’s navigating his own complicated family.
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial
Prior evidence suggests a progression-free survival (PFS) benefit from adding metastasis-directed therapy (MDT) to standard-of-care (SOC) systemic therapy for patients with some oligometastatic solid tumors.…
Vinay Prasad’s Observations and Thoughts | Substack
Medicine, Oncology, Health Policy. Click to read Vinay Prasad’s Observations and Thoughts, a Substack publication with tens of thousands of subscribers.
The Failing U.S. Health System | NEJM
New data show that the United States continues to fall short when it comes to both protecting the health of individual people and promoting societal…
Using AI technology, new Virginia Holocaust Museum exhibit brings survivor stories to life
The Virginia Holocaust Museum will soon unveil a new AI technology experience where visitors have the chance to ask questions to Holocaust survivors.
Leukemic myeloblasts with erythrophagocytosis
An 80-year-old woman was diagnosed with acute myeloid leukemia (AML). Bone marrow aspirate revealed increased large-sized myeloblasts with scant cytoplasm, irregular nuclei, and fine chromatin.…
Cell biologist earns 2024 Block Lectureship Award at Ohio State
A Nobel Prize winner has added a new honor to his list of accomplishments — recipient of the 2024 Block Lectureship Award.
NHLBI’s Implementation Science Showcase Page: The Latest in Research, Grants, and Career Opportunities
Welcome to the new National Heart, Lung, and Blood Institute’s (NHLBI) Implementation Science Showcase page! This page is your go-to source for the latest in…
Dr Miller on the Efficacy of Selinexor in TP53 Wild-Type Endometrial Cancer
David S. Miller, MD, discusses the efficacy of selinexor in patients with advanced or recurrent TP53 wild-type endometrial cancer.
NHLBI – Blood Research & Education | LinkedIn
NHLBI – Blood Research & Education | 34 followers on LinkedIn. Advancing science. Improving health. | NHLBI has several major research goals in blood diseases.…
